Merck & Company, Inc. News Headlines

MRK 
$56.26
*  
0.21
 negative 
0.37%
Get MRK Alerts
*Delayed - data as of Apr. 16, 2014 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Greece Prompts a 125-Point Slide for Dow; JPM Still Not Forgotten
5/14/2012 4:35:15 PM - Schaeffer's Investment Research

Simcere Misses on all Fronts - Analyst Blog
5/10/2012 10:08:32 AM - Zacks.com

JP Morgan Reiterates “Overweight” Rating on Merck (MRK)
5/8/2012 8:42:27 AM - Dividend.com

Best Health Care Investor Edward Owens Buys One New Health Care Stock in First Quarter
4/30/2012 8:30:10 PM - GuruFocus

Dow Emerges from April Unscathed; SPX, COMP Not So Lucky
4/30/2012 4:35:33 PM - Schaeffer's Investment Research

Dow Emerges from April Unscathed; SPX, COMP Not So Lucky
4/30/2012 4:35:33 PM - Schaeffer's Investment Research

Merck Beats by a Penny; Affirms View - Analyst Blog
4/27/2012 10:45:01 AM - Zacks.com

Ahead of Wall Street - April 27, 2012 - Ahead of Wall Street
4/27/2012 9:50:40 AM - Zacks.com

GDP Headline Weak, Stronger Underneath - Analyst Blog
4/27/2012 9:49:28 AM - Zacks.com

Merck’s Profit Beats, but Revenue Misses (MRK)
4/27/2012 9:18:54 AM - Dividend.com

Earnings Preview: Merck - Analyst Blog
4/25/2012 5:50:01 PM - Zacks.com

Dow Takes a Triple-Digit Ride as the Street Chews On Apple
4/24/2012 4:35:01 PM - Schaeffer's Investment Research

Dow Takes a Triple-Digit Ride as the Street Chews On Apple
4/24/2012 4:35:01 PM - Schaeffer's Investment Research

Merck in Oncology Deal - Analyst Blog
4/19/2012 6:30:01 PM - Zacks.com

3 Things You Must Learn From Your Tax Return
4/17/2012 10:06:26 AM - Motley Fool

Company News for April 17, 2012 - Corporate Summary
4/17/2012 9:49:51 AM - Zacks.com

After Hours Most Active for Apr 13, 2012 : JPM, T, PG, MRK, VZ, CTL, AAXJ, ATVI, QQQ, HAS, AERL, QCOM
4/13/2012 4:42:08 PM - NASDAQ.com News

Smart Investors Need to Dump This "Comeback Stock" Before it's Too Late
4/11/2012 10:00:00 AM - David Sterman

SNY Expands Animal Health Business - Analyst Blog
4/5/2012 1:41:49 PM - Zacks.com

Positive Vote for Glaxo's Votrient - Analyst Blog
3/23/2012 4:15:01 PM - Zacks.com

Temodar Generic Cleared Down Under - Analyst Blog
3/22/2012 9:23:03 AM - Zacks.com

Panel Votes Against Merck-ARIAD Drug - Analyst Blog
3/21/2012 3:22:32 PM - Zacks.com

Merck Drops Oral Vernakalant - Analyst Blog
3/20/2012 3:15:01 PM - Zacks.com

Performance Metrics: Similar Considerations For Income And Total Return Investors
3/16/2012 11:54:00 AM - Seeking Alpha

Dividend Portfolio Playoffs - Aristocrats Start Appearing
3/16/2012 9:34:00 AM - Seeking Alpha